華廣 News Releases

[Hwa Guang] Announcement of Important Resolutions from the 115th Annual Shareholders' Meeting

Hwa Guang held its annual shareholders' meeting on June 26, 2026, approving the loss allocation for … · 2026-06-26

Hwa Guang Announces Shareholders' Approval to Lift Non-Competition Restriction for Director Fan Pu

On June 26, 2026, Hwa Guang's annual shareholders' meeting approved the lifting of non-competition r… · 2026-06-26

Huagung: Announcement of the Board Meeting Date for Q1 2026 Financial Report on May 13, 2026

Huagung announced on May 5, 2026, that a board meeting to discuss its Q1 2026 financial report is sc… · 2026-05-13

Bionime Announces Board Approval of Q1 2026 Consolidated Financial Report

Bionime Corporation announced on May 13, 2026, the board's approval of its Q1 2026 consolidated fina… · 2026-05-13

Huagung: Announcement of the Board Meeting Date for Q1 2026 Financial Report on May 13, 2026

Huagung announced on May 5, 2026, that a board meeting to discuss its Q1 2026 financial report is sc… · 2026-05-13

Bionime Announces Board Approval of Q1 2026 Consolidated Financial Report

Bionime Corporation announced on May 13, 2026, the board's approval of its Q1 2026 consolidated fina… · 2026-05-13

[Bionime] May 2026 Revenue Reaches NT$142 Million (YoY -13.5%)

Bionime announced its monthly revenue for May 2026, reaching NT$141.7 million, down 13.5% compared t… · 2026-05-01

【Bionime】Announcement: Company's "RIGHTEST iFree2 Continuous Glucose Monitoring System (CGM)" Obtains Class II Medical Device Approval Notice from Taiwan Food and Drug Administration (TFDA)

Bionime Corporation announced that its second-generation continuous glucose monitoring system, "RIGH… · 2026-04-29

【Bionime】Announcement: Company's "RIGHTEST iFree2 Continuous Glucose Monitoring System (CGM)" Obtains Class II Medical Device Approval Notice from Taiwan Food and Drug Administration (TFDA)

Bionime Corporation announced that its second-generation continuous glucose monitoring system, "RIGH… · 2026-04-29

【Huaguang】April 2026 Revenue 141 Million (YoY -8.4%)

Huaguang announced its April 2026 monthly revenue of 141 million yuan, a decrease of 8.4% year-on-ye… · 2026-04-01

【Huaguang】April 2026 Revenue 141 Million (YoY -8.4%)

Huaguang announced its April 2026 monthly revenue of 141 million yuan, a decrease of 8.4% year-on-ye… · 2026-04-01

[Bionime Corp.] March 2026 Revenue NT$167M (YoY +4.7%)

Bionime Corp. announced its monthly revenue for March 2026 was NT$167 million, a 4.7% increase year-… · 2026-03-01

[Bionime Corp.] March 2026 Revenue NT$167M (YoY +4.7%)

Bionime Corp. announced its monthly revenue for March 2026 was NT$167 million, a 4.7% increase year-… · 2026-03-01

[Huagung] February 2026 Revenue NT$111 Million (YoY -28.9%)

Huagung (stock code: 4737) announced its revenue report for February 2026. The revenue for the month… · 2026-02-01

[Huagung] February 2026 Revenue NT$111 Million (YoY -28.9%)

Huagung (stock code: 4737) announced its revenue report for February 2026. The revenue for the month… · 2026-02-01